Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1/2 3Phase 1 3Phase EARLY_PHASE1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Genistein × Clear all
NCT02075112 2019-12-06

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Emory University

Phase 1 Completed
24 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00099008 2013-05-21

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
30 enrolled
BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡